Skip to main content

Table 3 Summary of treatment-emergent AEs (safety population)

From: Zishen pingchan granules combined with pramipexole in the improvement of depressive symptoms in Parkinson's disease: a prospective, multicenter, randomized, double-blind, controlled clinical study

Event

Zishen Pingchan (n = 99)

Placebo (n = 100)

Nausea

2 (2.0%)

2 (2.0%)

Diarrhea

1 (1.0%)

0

Abdominal pain

1 (1.0%)

0

Vomiting

1 (1.0%)

0

Stomach pain

1 (1.0%)

2 (2.0%)

Facial swelling

1 (1.0%)

0

Constipation

0

2 (2.0%)

Abnormal liver function

0

2 (2.0%)

Muscle aches

0

1 (1.0%)

Total

7 (7.1%)

9 (9.0%)

  1. Data are reported as n (%)
  2. AE, adverse event